FDA Brief

Warning letters Drugs

FDA warning letter to

Noble Elements, LLC

High riskIssued Jan 30, 2023Posted Jan 31, 2023Center for Food Safety and Applied Nutrition (CFSAN)

FDA warns Noble Elements over unapproved, misbranded Coated Silver drug claims on its website.

What happened

FDA reviewed www.coatedsilver.com in October 2022 and found the site takes orders for Coated Silver. FDA cited blog posts claiming colloidal silver has antimicrobial effects and kills bacteria, viruses and fungi, with references to monkeypox, HSV-1 and HIV-1. FDA said those claims establish the product is intended as a drug for disease use, making it an unapproved new drug and misbranded.

What FDA found

  1. Website claims that Coated Silver kills bacteria, viruses and fungi and is useful against diseases such as monkeypox, HSV-1 and HIV-1 make it a drug intended to treat or prevent disease.

    section 201(g)(1)(B) of the Act [21 U.S.C. 321(g)(1)(B)]
  2. FDA says Coated Silver is not generally recognized as safe and effective for the claimed uses, so it is a new drug.

    section 201(p) of the Act [21 U.S.C. 321(p)]
  3. Coated Silver is an unapproved new drug because FDA has not approved it for those uses.

    section 505(a) of the Act [21 U.S.C. 355(a)]
  4. The product is misbranded because it lacks adequate directions for a layperson to use it safely for its intended disease uses.

    section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]
  5. Introducing or delivering the misbranded drug into interstate commerce violates the Act.

    section 301(a) of the Act [21 U.S.C. 331(a)]

What FDA wants

FDA asks the company to stop selling any unapproved or unauthorized products claimed to mitigate, prevent, treat, diagnose, or cure mpox and to reply in writing within 15 working days with the steps taken and related documentation.

Who should pay attention

  • e-commerce sellers of colloidal silver or supplements
  • marketing and compliance teams that review website disease claims
  • retailers and marketplaces listing drug-like supplement products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk